newsfilter
← Latest News
ACCESS Newswire·

Tenon Medical(R) Adds Eight New Patents Issued by the United States Patent and Trademark Office Through Q3 2026

  • Tenon Medical, Inc. received 8 new patents from the USPTO in the 2026 fiscal year ending October 15, 2026.
  • The company's intellectual property portfolio now includes 38 issued U.S. patents & 9 international patents.
  • Tenon currently has 31 patent applications pending in both U.S. & foreign jurisdictions.
  • New patents provide protection for the Catamaran SI Joint Fusion System, which covers strategic systems & method claims.
  • The company anticipates further additions to its IP portfolio & several product launches in upcoming quarters.
  • Tenon estimates the potential U.S. market for SI joint dysfunction surgical treatment at approximately 270,000 procedures & $2.1 billion annually.
  • The company views defensible IP as a barrier to competitors & a driver for physician adoption.
  • Tenon markets the SImmetry SI Joint Fusion System, acquired in August 2025, & is seeking additional patent protection for this platform.
  • Richard Ginn, Chief Technology Officer & Chief Operations Officer, stated that the new patents result from physician feedback & aim to strengthen protection around Catamaran.
  • Pending patent applications are expected to expire beginning around 2031.
  • Tenon focuses commercial efforts on primary SI joint procedures, revision procedures, & SI joint fusion adjuncts to spine fusion constructs.